ADHD Medications: Risk, Bias, and Real Outcomes
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
ADHD Medications: Risk, Bias, and Real Outcomes
-
Narrated by:
-
Written by:
About this listen
Title: ADHD Medications: Risk, Bias, and Real Outcomes
Hosts: James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC
In this first episode of Compass Point Institute, James and Jon break down a major new study published in JAMA Psychiatry (June 25, 2025) tracking ADHD medication outcomes in over 260,000 individuals.
🎯 Topics covered:
- Key findings from a 15-year longitudinal study
- Reduced self-harm, accident, and criminal risk
- Navigating stigma, DEA scrutiny, and Schedule II status
- Provider bias and the myth of “weekend breaks”
- Practical clinical guidance on stimulant prescribing
- The difference between physiological vs psychological addiction
This episode is designed to support mental health clinicians with real-world data, clear context, and grounded insight.
📬 Have a topic you want us to cover? Reach out anytime.
🧭 Compass Point Institute — Empowering the next generation of mental health clinicians.
No reviews yet